Heinz, Katja C. http://orcid.org/0009-0002-2148-0675
Beaudart, Charlotte http://orcid.org/0000-0002-0827-5303
Willems, Damon http://orcid.org/0000-0001-8263-4047
Hiligsmann, Mickaël http://orcid.org/0000-0003-4274-9258
Article History
Accepted: 8 April 2024
First Online: 9 May 2024
Declarations
:
: No funding was received for conducting this study.
: Katja C. Heinz, Charlotte Beaudart and Mickaël Hiligsmann have no competing interests to declare that are relevant to the contents of this article. Damon Willems is also an employee of UCB Pharma, but UCB Pharma had no role in the design, conduct, and analysis of the study, or in the writing/reviewing of this manuscript.
: All data generated and/or analyzed during this study are included in this published article and its Online Resource files.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the study conception and design. Material preparation and data collection and analysis were performed by all authors. The first draft of the manuscript was written by KH and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.